Veterinarians successfully used a treatment option from human medicine to reduce squamous cell carcinomas in horses’ eyes.
Belgian horses with two copies of the DDB2 genetic variant are four times more likely to develop ocular squamous cell carcinoma (SCC) than those with one or no copies, researchers found.
Study findings suggest dose escalation can be used in equine lymphoma treatment to achieve higher chemotherapeutic dose intensity while minimizing adverse effects, researchers said.
Find out what conditions, beyond lameness, a veterinarian might uncover during a prepurchase exam.
Squamous cell carcinoma is the most common cancer found in equine eyes and the second most common equine tumor overall.
Studying diseases across species can benefit horses as well as people.
Stay on top of the most recent Horse Health news with